Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Angstrom Technologies, Inc. (AGTT)
Florence, KY, US
Angstrom Technologies, Inc. specializes in developing and supplying ultraviolet (UV) fluorescent chemical products, alongside sophisticated electronic detection systems. Their comprehensive offerings are designed to provide solutions across various critical areas, including bolstering security, deterring fraudulent activities, ensuring brand protection, optimizing manufacturing process control, and facilitating track-and-trace capabilities within industrial settings. The company's UV fluorescent chemical portfolio features a range of products such as invisible, daylight-visible, and phosphorescent chemicals, which are also available as specialized inks and varnishes. These are applied in diverse fields including security applications, scientific research, industrial process management, and entertainment. Furthermore, Angstrom provides tailored chemistry services. In terms of electronic solutions, their product line includes various fluorescence detection systems, associated accessories, and UV lighting equipment. A prominent offering is the MoneyChecker, a dedicated device for authenticating US currency and other important documents in retail points-of-sale or office environments. Angstrom serves a wide array of clients, including governmental organizations, private corporations, and financial institutions. Founded in 1983, the company maintains its operational base in Florence, Kentucky.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | -21.43% | -26.67% | -8.33% | -8.33% | -57.69% | +10.00% | +83.33% | +54.93% | -31.25% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Chemicals: +4.0%-7.4% Q4'25: -143.5% (vs Q3'24)
-
EPS growth Chemicals: +11.7%+149.3% ★ Q4'25: -113.2% (vs Q3'24)
-
FCF margin FCF growth · Chemicals: +41.7%+12.9% ★ Q4'25: -17.1% (vs Q3'24)
-
EBIT margin Chemicals: +7.1%+7.7% ★ Q4'25: +5.3% (vs Q3'24)
-
ROIC Chemicals: +3.4%+12.4% ★ Q4'25: -17.5% (vs Q3'24)
-
Share dilution Chemicals: +0.0%-3.1% ★ Q4'25: +0.0% (vs Q3'24)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×0.00× ★ Q4'25: 0.00× (vs Q3'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-18 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Brian Dempsey | Director of Technical Services | — | — |
| Darlene Moser | Accounting Department Manager | — | — |
| Jennifer Biro | President of Life Sciences Division | — | female |
| Tony Petrucci | Chief Executive Officer & President | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AGTT
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
